Comprehensive review on lactate metabolism in human health

Mitochondrion

Volumn 17, Issue , 2014, Pages 76-100

  Adeva Andany, M ^a   Lopez Ojen M ^b   Funcasta Calderon R ^a   Ameneiros Rodriguez E ^a   Donapetry Garcia C ^a   Vila Altesor, M ^a   Rodriguez Seijas J ^a  

^a Hospital General Juan Cardona   (Spain)

^b C Federico García   (Spain)

Author keywords

Diabetes mellitus; Gluconeogenesis; Glycolysis; Insulin resistance; Respiratory chain; Tricarboxylic acid cycle

Indexed keywords

ALANINE; ALCOHOL; BICARBONATE; CARBON MONOXIDE; CITRATE SYNTHASE; CYANIDE; ETHYLENE GLYCOL; FRUCTOSE; GLUCOSE; INSULIN; LACTIC ACID; LINEZOLID; METFORMIN; METHANOL; MITOCHONDRIAL DNA; MONOCARBOXYLATE TRANSPORTER; OXYGEN; PARACETAMOL; PENTOSE PHOSPHATE; PHENFORMIN; PROPYLENE GLYCOL; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; RNA DIRECTED DNA POLYMERASE INHIBITOR; SODIUM COUPLED MONOCARBOXYLATE TRANSPORTER; SODIUM COUPLED MONOCARBOXYLATE TRANSPORTER 1; SODIUM COUPLED MONOCARBOXYLATE TRANSPORTER 2; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; CARBON DIOXIDE; OXIDOREDUCTASE;

ACQUIRED MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION; ACTIVE SKELETAL MUSCLE; ACUTE LIVER FAILURE; ADIPOSE TISSUE; AEROBIC METABOLISM; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; ASTHMA; BLOOD CELL; BRAIN; CARBON MONOXIDE INTOXICATION; CELL MEMBRANE; CONGENITAL MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION; CONGENITAL PYRUVATE CARBOXYLASE DEFICIENCY; CRITICAL ILLNESS; CYANIDE POISONING; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; DRUG OVERDOSE; ENDURANCE TRAINING; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SUBSTRATE; EXERCISE; GENE; GENE MUTATION; GLUCOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HEALTH; HEART; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY; LACTIC ACIDOSIS; LIVER; LIVER DISEASE; LUNG; MALIGNANT NEOPLASTIC DISEASE; MCT1 GENE; MCT2 GENE; MCT3 GENE; MCT4 GENE; METABOLIC CLEARANCE RATE; METABOLIC DISORDER; MITOCHONDRION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN TRANSPORT; PATHOGENESIS; PDHA1 GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTON TRANSPORT; RESTING SKELETAL MUSCLE; REVIEW; REYE SYNDROME; SEPSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SLC16 GENE; SLC5A12 GENE; SLC5A8 GENE; SMCT1 GENE; SMCT2 GENE; SPLANCHNIC PLEXUS; THIAMINE DEFICIENCY; TRICARBOXYLIC ACID DYSFUNCTION; METABOLISM; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

ALANINE; CARBON DIOXIDE; DIABETES MELLITUS; GLUCOSE; HUMANS; LACTIC ACID; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; NEOPLASMS; OXIDATION-REDUCTION; OXIDOREDUCTASES; OXYGEN; PYRUVIC ACID;

EID: 84903149605     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.05.007     Document Type: Review

References (306)

1. Abbot E.L., McCormack J.G., Reynet C., Hassall D.G., Buchan K.W., Yeaman S.J. Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells. FEBS J. 2005, 272(12):3004-3014.
2. Aber G.M., Morris L.O., Housley E. Gluconeogenesis by the human kidney. Nature 1966, 212(5070):1589-1590.
3. Ahlborg G., Felig P. Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise. J. Clin. Invest. 1982, 69(1):45-54.
4. Ahlborg G., Felig P., Hagenfeldt L., Hendler R., Wahren J. Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J. Clin. Invest. 1974, 53(4):1080-1090.
5. Ahlborg G., Hagenfeldt L., Wahren J. Substrate utilization by the inactive leg during one-leg or arm exercise. J. Appl. Physiol. 1975, 39(5):718-723.
6. Ananth S., Zhuang L., Gopal E., Itagaki S., Ellappan B., Smith S.B., Ganapathy V., Martin P. Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon. Biochem. Biophys. Res. Commun. 2010, 394(1):75-80.
7. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119(3):573-581.
8. Andres R., Cader G., Zierler K.L. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J. Clin. Invest. 1956, 35(6):671-682.
9. Avogaro A., Toffolo G., Miola M., Valerio A., Tiengo A., Cobelli C., Del Prato S. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J. Clin. Invest. 1996, 98(1):108-115.
10. Bajpeyi S., Pasarica M., Moro C., Conley K., Jubrias S., Sereda O., Burk D.H., Zhang Z., Gupta A., Kjems L., Smith S.R. Skeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes. J. Clin. Endocrinol. Metab. 2011, 96(4):1160-1168.
11. Barnett A.H., Spiliopoulos A.J., Pyke D.A., Stubbs W.A., Burrin J., Alberti K.G. Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. Br. Med. J. (Clin. Res. Ed.) 1981, 282(6277):1656-1658.
12. Battezzati A., Caumo A., Martino F., Sereni L.P., Coppa J., Romito R., Ammatuna M., Regalia E., Matthews D.E., Mazzaferro V., Luzi L. Nonhepatic glucose production in humans. Am. J. Physiol. Endocrinol. Metab. 2004, 286(1):E129-E135.
13. Baud F.J., Borron S.W., Megarbane B., Trout H., Lapostolle F., Vicaut E., Debray M., Bismuth C. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit. Care Med. 2002, 30(9):2044-2050.
14. Baverel G., Bonnard M., Pellet M. Lactate and pyruvate metabolism in isolated human kidney tubules. FEBS Lett. 1979, 101(2):282-286.
15. Beck-Nielsen H. The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes: 'to store or not to store glucose, that's the question'. Diabetes Metab. Res. Rev. 2012, 28(8):635-644.
16. Benaissa M.L., Megarbane B., Borron S.W., Baud F.J. Is elevated plasma lactate a useful marker in the evaluation of pure carbon monoxide poisoning?. Intensive Care Med. 2003, 29(8):1372-1375.
17. Bental M., Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn. Reson. Med. 1993, 29(3):317-326.
18. Bergman B.C., Wolfel E.E., Butterfield G.E., Lopaschuk G.D., Casazza G.A., Horning M.A., Brooks G.A. Active muscle and whole body lactate kinetics after endurance training in men. J. Appl. Physiol. 1999, 87(5):1684-1696.
19. Bergman B.C., Tsvetkova T., Lowes B., Wolfel E.E. Myocardial glucose and lactate metabolism during rest and atrial pacing in humans. J. Physiol. 2009, 587(Pt 9):2087-2099.
20. Bernal W., Donaldson N., Wyncoll D., Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359(9306):558-563.
21. Bihari D., Gimson A.E., Lindridge J., Williams R. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J. Hepatol. 1985, 1(4):405-416.
22. Bokhari S., Emerson P., Israelian Z., Gupta A., Meyer C. Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2009, 296(3):E440-E444.
23. Bonen A. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. Eur. J. Appl. Physiol. 2001, 86(1):6-11.
24. Bonen A., McCullagh K.J., Putman C.T., Hultman E., Jones N.L., Heigenhauser G.J. Short-term training increases human muscle MCT1 and femoral venous lactate in relation to muscle lactate. Am. J. Physiol. 1998, 274(1 Pt 1):E102-E107.
25. Bonnefont J.P., Chretien D., Rustin P., Robinson B., Vassault A., Aupetit J., Charpentier C., Rabier D., Saudubray J.M., Munnich A. Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J. Pediatr. 1992, 121(2):255-258.
26. Borregaard N., Herlin T. Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 1982, 70(3):550-557.
27. Borron S.W., Baud F.J. Antidotes for acute cyanide poisoning. Curr. Pharm. Biotechnol. 2012, 13(10):1940-1948.
28. Borthakur A., Gill R.K., Hodges K., Ramaswamy K., Hecht G., Dudeja P.K. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290(1):G30-G35.
29. 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 2010, 30(42):13983-13991.
30. Bouteldja N., Timson D.J. The biochemical basis of hereditary fructose intolerance. J. Inherit. Metab. Dis. 2010, 33(2):105-112.
31. Bricker D.K., Taylor E.B., Schell J.C., Orsak T., Boutron A., Chen Y.C., Cox J.E., Cardon C.M., Van Vranken J.G., Dephoure N., Redin C., Boudina S., Gygi S.P., Brivet M., Thummel C.S., Rutter J. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 2012, 337(6090):96-100.
32. Brindley P.G., Butler M.S., Cembrowski G., Brindley D.N. Falsely elevated point-of-care lactate measurement after ingestion of ethylene glycol. CMAJ 2007, 176(8):1097-1099.
33. Brown S.D., Clark C., Gutierrez G. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J. Crit. Care 1996, 11(1):2-8.
34. Brown J.B., Pedula K., Barzilay J., Herson M.K., Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998, 21(10):1659-1663.
35. Bruce C.R., Anderson M.J., Carey A.L., Newman D.G., Bonen A., Kriketos A.D., Cooney G.J., Hawley J.A. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 2003, 88(11):5444-5451.
36. Cahill G.F., Herrera M.G., Morgan A.P., Soeldner J.S., Steinke J., Levy P.L., Reichard G.A., Kipnis D.M. Hormone-fuel interrelationships during fasting. J. Clin. Invest. 1966, 45(11):1751-1769.
37. Cao H., van der Veer E., Ban M.R., Hanley A.J., Zinman B., Harris S.B., Young T.K., Pickering J.G., Hegele R.A. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2004, 89(2):898-903.
38. Capaldo B., Napoli R., Di Bonito P., Albano G., Saccà L. Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients. J. Clin. Endocrinol. Metab. 1990, 71(5):1220-1223.
39. Centers for Disease Control and Prevention Lactic acidosis traced to thiamine deficiency related to nationwide shortage of multivitamins for total parenteral nutrition-United States. JAMA 1997, 278(2):109-111.
40. Cersosimo E., Garlick P., Ferretti J. Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes 2000, 49(7):1186-1193.
41. Chan C.B., Harper M.E. Uncoupling proteins: role in insulin resistance and insulin insufficiency. Curr. Diabetes Rev. 2006, 2(3):271-283.
42. Chen Y.T., Scheinman J.I., Park H.K., Coleman R.A., Roe C.R. Amelioration of proximal renal tubular dysfunction in type I glycogen storage. N. Engl. J. Med. 1990, 323(9):590-593.
43. Chen Y.D., Varasteh B.B., Reaven G.M. Plasma lactate concentration in obesity and type 2 diabetes. Diabete Metab. 1993, 19(4):348-354.
44. Cheng C., Edin N.F., Lauritzen K.H., Aspmodal I., Christoffersen S., Jian L., Rasmussen L.J., Pettersen E.O., Xiaoqun G., Bergersen L.H. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. Cell. Oncol. 2012, 35(3):217-227.
45. Chi S.J., Stein E., Chaney M.A., Ranucci M., Wall M.H. Severe lactic acidosis during cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2009, 23(5):711-719.
46. Chiolero R., Tappy L., Gillet M., Revelly J.P., Roth H., Cayeux C., Schneiter P., Leverve X. Effect of major hepatectomy on glucose and lactate metabolism. Ann. Surg. 1999, 229(4):505-513.
47. Choi S.Y., Collins C.C., Gout P.W., Wang Y. Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?. J. Pathol. 2013, 230(4):350-355.
48. Christensen N.J., Alberti K.G., Brandsborg O. Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur. J. Clin. Invest. 1975, 5(5):415-423.
49. +-monocarboxylate cotransporter. J. Physiol. 2004, 557(Pt 3):719-731.
50. +/monocarboxylate cotransporter SMCT1. Am. J. Physiol. Cell Physiol. 2010, 298(1):C124-C131.
51. Connor H., Woods H.F., Ledingham J.G. Comparison of the kinetics and utilisation of d(-)- and l(+)-sodium lactate in normal man. Ann. Nutr. Metab. 1983, 27(6):481-487.
52. Consoli A., Nurjhan N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989, 38(5):550-557.
53. Consoli A., Nurjhan N., Reilly J.J., Bier D.M., Gerich J.E. Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am. J. Physiol. 1990, 259(5 Pt 1):E677-E684.
54. Cope T.E., McFarland R., Schaefer A. Rapid-onset, linezolid-induced lactic acidosis in MELAS. Mitochondrion 2011, 11(6):992-993.
55. Coppack S.W., Frayn K.N., Humphreys S.M., Whyte P.L., Hockaday T.D. Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism 1990, 39(4):384-390. Apr.
56. Coppack S.W., Fisher R.M., Humphreys S.M., Clark M.L., Pointon J.J., Frayn K.N. Carbohydrate metabolism in insulin resistance: glucose uptake and lactate production by adipose and forearm tissues in vivo before and after a mixed meal. Clin. Sci. (Lond.) 1996, 90(5):409-415.
57. Cox K., Cocchi M.N., Salciccioli J.D., Carney E., Howell M., Donnino M.W. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J. Crit. Care 2012, 27(2):132-137.
58. Crawford S.O., Ambrose M.S., Hoogeveen R.C., Brancati F.L., Ballantyne C.M., Young J.H. Association of lactate with blood pressure before and after rapid weight loss. Am. J. Hypertens. 2008, 21(12):1337-1342.
59. Crawford S.O., Hoogeveen R.C., Brancati F.L., Astor B.C., Ballantyne C.M., Schmidt M.I., Young J.H. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int. J. Epidemiol. 2010, 39(6):1647-1655.
60. Cruickshank A.M., Telfer A.B., Shenkin A. Thiamine deficiency in the critically ill. Intensive Care Med. 1988, 14(4):384-387.
61. Cuff M.A., Shirazi-Beechey S.P. The human monocarboxylate transporter, MCT1: genomic organization and promoter analysis. Biochem. Biophys. Res. Commun. 2002, 292(4):1048-1056.
62. Dahlman I., Forsgren M., Sjögren A., Nordström E.A., Kaaman M., Näslund E., Attersand A., Arner P. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 2006, 55(6):1792-1799.
63. Dalsgaard M.K., Quistorff B., Danielsen E.R., Selmer C., Vogelsang T., Secher N.H. A reduced cerebral metabolic ratio in exercise reflects metabolism and not accumulation of lactate within the human brain. J. Physiol. 2004, 554(Pt 2):571-578.
64. de Groot R., Sprenger R.A., Imholz A.L., Gerding M.N. Type B lactic acidosis in solid malignancies. Neth. J. Med. 2011, 69(3):120-123.
65. de Vrese M., Koppenhoefer B., Barth C.A. d-lactic acid metabolism after an oral load of dl-lactate. Clin. Nutr. 1990, 9(1):23-28.
66. De Vriese A.S., Coster R.V., Smet J., Seneca S., Lovering A., Van Haute L.L., Vanopdenbosch L.J., Martin J.J., Groote C.C., Vandecasteele S., Boelaert J.R. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin. Infect. Dis. 2006, 42(8):1111-1117.
67. DeFronzo R.A., Goodman A.M. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N. Engl. J. Med. 1995, 333(9):541-549.
68. DeFronzo R.A., Barzilai N., Simonson D.C. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J. Clin. Endocrinol. Metab. 1991, 73(6):1294-1301.
69. Del Prato S., Bonadonna R.C., Bonora E., Gulli G., Solini A., Shank M., DeFronzo R.A. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J. Clin. Invest. 1993, 91(2):484-494.
70. Diamant B., Karlsson J., Saltin B. Muscle tissue lactate after maximal exercise in man. Acta Physiol. Scand. 1968, 72(3):383-384.
71. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348(26):2656-2668.
72. Donnino M.W., Miller J., Garcia A.J., McKee E., Walsh M. Distinctive acid-base pattern in Wernicke's encephalopathy. Ann. Emerg. Med. 2007, 50(6):722-725.
73. Druml W., Kleinberger G., Lenz K., Laggner A., Schneeweiss B. Fructose-induced hyperlactemia in hyperosmolar syndromes. Klin. Wochenschr. 1986, 64(13):615-618.
74. Dubouchaud H., Butterfield G.E., Wolfel E.E., Bergman B.C., Brooks G.A. Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000, 278(4):E571-E579.
75. Elbein S.C., Kern P.A., Rasouli N., Yao-Borengasser A., Sharma N.K., Das S.K. Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. Diabetes 2011, 60(3):1019-1029.
76. Epker J.L., Bakker J. Accidental methanol ingestion: case report. BMC Emerg. Med. 2010, 10:3.
77. Essa E., Velez M.R., Smith S., Giri S., Raman S.V., Gumina R.J. Cardiovascular magnetic resonance in wet beriberi. J. Cardiovasc. Magn. Reson. 2011, 13:41.
78. Eudy J.D., Spiegelstein O., Barber R.C., Wlodarczyk B.J., Talbot J., Finnell R.H. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol. Genet. Metab. 2000, 71(4):581-590.
79. 13C-NMR. Arch. Toxicol. 2011, 85(9):1067-1077.
80. Fannin R.D., Russo M., O'Connell T.M., Gerrish K., Winnike J.H., Macdonald J., Newton J., Malik S., Sieber S.O., Parker J., Shah R., Zhou T., Watkins P.B., Paules R.S. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2010, 51(1):227-236.
81. Felig P., Wahren J. Amino acid metabolism in exercising man. J. Clin. Invest. 1971, 50(12):2703-2714.
82. Felig P., Wahren J. Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J. Clin. Invest. 1971, 50(8):1702-1711.
83. Felig P., Wahren J., Hendler R. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes 1978, 27(2):121-126.
84. Fernandes J., Berger R., Smit G.P. Lactate as energy source for brain in glucose-6-phosphatase deficient child. Lancet 1982, 1(8263):113.
85. Ferriero R., Brunetti-Pierri N. Anti-cancer drug phenylbutyrate increases activity of pyruvate dehydrogenase complex. Oncotarget 2013, 4(6):804-805.
86. Fisher D.S., Bowskill S., Saliba L., Flanagan R.J. Unintentional domestic non-fire related carbon monoxide poisoning: data from media reports, UK/Republic of Ireland 1986-2011. Clin. Toxicol. (Phila) 2013, 51(5):409-416.
87. Fisher-Wellman K.H., Neufer P.D. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol. Metab. 2012, 23(3):142-153.
88. Fleming J.C., Tartaglini E., Steinkamp M.P., Schorderet D.F., Cohen N., Neufeld E.J. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat. Genet. 1999, 22(3):305-308.
89. Fontenot A.P., Pelak V.S. Development of neurologic symptoms in a 26-year-old woman following recovery from methanol intoxication. Chest 2002, 122(4):1436-1439.
90. Fox P.T., Raichle M.E., Mintun M.A., Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988, 241(4864):462-464.
91. Fraley D.S., Adler S., Bruns F.J., Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with a solid neoplasm and lactic acidosis. N. Engl. J. Med. 1980, 303(19):1100-1102.
92. Frayn K.N., Humphreys S.M. Metabolic characteristics of human subcutaneous abdominal adipose tissue after overnight fast. Am. J. Physiol. Endocrinol. Metab. 2012, 302(4):E468-E475.
93. Frederiksen C.M., Hojlund K., Hansen L., Oakeley E.J., Hemmings B., Abdallah B.M., Brusgaard K., Beck-Nielsen H., Gaster M. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia 2008, 51(11):2068-2077.
94. Friedman J.E., Caro J.F., Pories W.J., Azevedo J.L., Dohm G.L. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism 1994, 43(8):1047-1054.
95. Fulop M., Hoberman H.D., Rascoff J.H., Bonheim N.A., Dreyer N.P., Tannenbaum H. Lactic acidosis in diabetic patients. Arch. Intern. Med. 1976, 136(9):987-990.
96. 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study. Brain 2009, 132(Pt 10):2839-2849.
97. Garcia C.K., Li X., Luna J., Francke U. cDNA cloning of the human monocarboxylate transporter 1 and chromosomal localization of the SLC16A1 locus to 1p13.2-p12. Genomics 1994, 23(2):500-503.
98. Garibotto G., Sofia A., Robaudo C., Saffioti S., Sala M.R., Verzola D., Vettore M., Russo R., Procopio V., Deferrari G., Tessari P. Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis. J. Am. Soc. Nephrol. 2004, 15(6):1606-1615.
99. Gaster M. Reduced TCA flux in diabetic myotubes: determined by single defects?. Biochem. Res. Int. 2012, 2012:716056.
100. Gaster M., Petersen I., Hojlund K., Poulsen P., Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 2002, 51(4):921-927.
101. Gerlinger M., Santos C.R., Spencer-Dene B., Martinez P., Endesfelder D., Burrell R.A., Vetter M., Jiang M., Saunders R.E., Kelly G., Dykema K., Rioux-Leclercq N., Stamp G., Patard J.J., Larkin J., Howell M., Swanton C. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. J. Pathol. 2012, 227(2):146-156.
102. Gertz E.W., Wisneski J.A., Stanley W.C., Neese R.A. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J. Clin. Invest. 1988, 82(6):2017-2025.
103. Giebelstein J., Poschmann G., Hojlund K., Schechinger W., Dietrich J.W., Levin K., Beck-Nielsen H., Podwojski K., Stuhler K., Meyer H.E., Klein H.H. The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes. Diabetologia 2012, 55(4):1114-1127.
104. Glinghammar B., Rafter I., Lindström A.K., Hedberg J.J., Andersson H.B., Lindblom P., Berg A.L., Cotgreave I. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int. J. Mol. Med. 2009, 23(5):621-631.
105. Golay A., DeFronzo R.A., Ferrannini E., Simonson D.C., Thorin D., Acheson K., Thiebaud D., Curchod B., Jequier E., Felber J.P. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988, 31(8):585-591.
106. Goodgame J.T., Pizzo P., Brennan M.F. Iatrogenic lactic acidosis: association with hypertonic glucose administration in a patient with cancer. Cancer 1978, 42(2):800-803.
107. Goodwin M.L., Harris J.E., Hernández A., Gladden L.B. Blood lactate measurements and analysis during exercise: a guide for clinicians. J. Diabetes Sci. Technol. 2007, 1(4):558-569.
108. Gopal E., Miyauchi S., Martin P.M., Ananth S., Roon P., Smith S.B., Ganapathy V. Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res. 2007, 24(3):575-584.
109. Gopal E., Umapathy N.S., Martin P.M., Ananth S., Gnana-Prakasam J.P., Becker H., Wagner C.A., Ganapathy V., Prasad P.D. Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim. Biophys. Acta 2007, 1768(11):2690-2697.
110. Graham T.E., Saltin B. Estimation of the mitochondrial redox state in human skeletal muscle during exercise. J. Appl. Physiol. 1989, 66(2):561-566.
111. Hadjiagapiou C., Schmidt L., Dudeja P.K., Layden T.J., Ramaswamy K. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279(4):G775-G780.
112. Hagstrom E., Arner P., Ungerstedt U., Bolinder J. Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am. J. Physiol. 1990, 258(5 Pt 1):E888-E893.
113. Hampson N.B., Piantadosi C.A., Thom S.R., Weaver L.K. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am. J. Respir. Crit. Care Med. 2012, 186(11):1095-1101.
114. Harris P., Bateman M., Gloster J. The regional metabolism of lactate and pyruvate during exercise in patients with rheumatic heart disease. Clin. Sci. 1962, 23:545-560.
115. Heinig R.E., Clarke E.F., Waterhouse C. Lactic acidosis and liver disease. Arch. Intern. Med. 1979, 139(11):1229-1232.
116. Henry R.R., Abrams L., Nikoulina S., Ciaraldi T.P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 1995, 44(8):936-946.
117. Hey-Mogensen M., Hojlund K., Vind B.F., Wang L., Dela F., Beck-Nielsen H., Fernstrom M., Sahlin K. Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 2010, 53(9):1976-1985.
118. Hojlund K., Yi Z., Lefort N., Langlais P., Bowen B., Levin K., Beck-Nielsen H., Mandarino L.J. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 2010, 53(3):541-551.
119. Højlund K., Wrzesinski K., Larsen P.M., Fey S.J., Roepstorff P., Handberg A., Dela F., Vinten J., McCormack J.G., Reynet C., Beck-Nielsen H. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J. Biol. Chem. 2003, 278(12):10436-10442.
120. Højlund K., Mogensen M., Sahlin K., Beck-Nielsen H. Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinol. Metab. Clin. North Am. 2008, 37(3):713-731.
121. Holmäng A., Müller M., Andersson O.K., Lönnroth P. Minimal influence of blood flow on interstitial glucose and lactate-normal and insulin-resistant muscle. Am. J. Physiol. 1998, 274(3 Pt 1):E446-E452.
122. Hunt T.K. Excess pyruvate and lactate production occurs in sepsis and is not caused by anaerobic glycolysis. Ann. Surg. 1997, 226(1):108-109.
123. Huttner H.B., Berger C., Schwab S. Severe ethylene glycol intoxication mimicking acute basilar artery occlusion. Neurocrit. Care. 2005, 3(2):171-173.
124. Hutton J.C., O'Brien R.M. Glucose-6-phosphatase catalytic subunit gene family. J. Biol. Chem. 2009, 284(43):29241-29245.
125. 2 uptake in human brain during recovery from maximal exercise. J. Physiol. 2000, 522(Pt 1):159-164.
126. Ingaramo M., Beckett D. Selectivity in post-translational biotin addition to five human carboxylases. J. Biol. Chem. 2012, 287(3):1813-1822.
127. Iwase K., Higaki J., Yoon H.E., Mikata S., Miyazaki M., Kamiike W. Reduced thiamine (vitamin B1) levels following gastrectomy for gastric cancer. Gastric Cancer 2002, 5(2):77-82.
128. Jackson R.A., Hamling J.B., Blix P.M., Sim B.M., Hawa M.I., Jaspan J.B., Belin J., Nabarro J.D. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man. J. Clin. Endocrinol. Metab. 1986, 63(3):594-604.
129. Jackson R.A., Roshania R.D., Hawa M.I., Sim B.M., DiSilvio L. Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. J. Clin. Endocrinol. Metab. 1986, 63(3):541-549.
130. Jackson R.A., Hamling J.B., Sim B.M., Hawa M.I., Blix P.M., Nabarro J.D. Peripheral lactate and oxygen metabolism in man: the influence of oral glucose loading. Metabolism 1987, 36(2):144-150.
131. Jansson P.A., Smith U., Lönnroth P. Evidence for lactate production by human adipose tissue in vivo. Diabetologia 1990, 33(4):253-256. Apr.
132. Jansson P.A., Larsson A., Smith U., Lonnroth P. Lactate release from the subcutaneous tissue in lean and obese men. J. Clin. Invest. 1994, 93(1):240-246.
133. (UUR) mt 3243 A→G and ND-1 gene mt 3316 G→A mutations in Chinese patients with type 2 diabetes. Chin. Med. J. (Engl) 2001, 114(11):1205-1207.
134. Jitrapakdee S., St Maurice M., Rayment I., Cleland W.W., Wallace J.C., Attwood P.V. Structure, mechanism and regulation of pyruvate carboxylase. Biochem. J. 2008, 413(3):369-387.
135. Jones D.L., Greenaway T.M. Beware the thin, deaf 'type 2' diabetic: maternally inherited diabetes and deafness with systemic (mitochondrial) manifestations. Intern. Med. J. 2004, 34(8):517-518.
136. Jorens P.G., Demey H.E., Schepens P.J., Coucke V., Verpooten G.A., Couttenye M.M., Van Hoof V. Unusual d-lactic acid acidosis from propylene glycol metabolism in overdose. J. Toxicol. Clin. Toxicol. 2004, 42(2):163-169.
137. Jorfeldt L. Metabolism of l(+)-lactate in human skeletal muscle during exercise. Acta Physiol. Scand. Suppl. 1970, 338:1-67.
138. Juel C., Bangsbo J., Graham T., Saltin B. Lactate and potassium fluxes from human skeletal muscle during and after intense, dynamic, knee extensor exercise. Acta Physiol. Scand. 1990, 140(2):147-159.
139. Juel C., Holten M.K., Dela F. Effects of strength training on muscle lactate release and MCT1 and MCT4 content in healthy and type 2 diabetic humans. J. Physiol. 2004, 556(Pt 1):297-304.
140. Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., Tanabe Y., Sakura H., Awata T., Goto Y., et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N. Engl. J. Med. 1994, 330(14):962-968.
141. Katz J., Tayek J.A. Recycling of glucose and determination of the Cori Cycle and gluconeogenesis. Am. J. Physiol. 1999, 277(3 Pt 1):E401-E407.
142. Katz A., Broberg S., Sahlin K., Wahren J. Muscle ammonia and amino acid metabolism during dynamic exercise in man. Clin. Physiol. 1986, 6(4):365-379.
143. Kelleher J.K. Estimating gluconeogenesis with [U-13C]glucose: molecular condensation requires a molecular approach. Am. J. Physiol. 1999, 277(3 Pt 1):E395-E400.
144. Keller U., Mall T., Walter M., Bertel O., Mihatsch J.M., Ritz R. Phaeochromocytoma with lactic acidosis. Br. Med. J. 1978, 2(6137):606-607.
145. Kelley D.E., Mandarino L.J. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 1990, 86(6):1999-2007.
146. Kelley D.E., Mokan M., Mandarino L.J. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients. Diabetes Care 1993, 16(8):1158-1166.
147. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51(10):2944-2950.
148. Kelner M.J., Bailey D.N. Propylene glycol as a cause of lactic acidosis. J. Anal. Toxicol. 1985, 9(1):40-42.
149. Kern P.A., Simsolo R.B., Fournier M. Effect of weight loss on muscle fiber type, fiber size, capillarity, and succinate dehydrogenase activity in humans. J. Clin. Endocrinol. Metab. 1999, 84(11):4185-4190.
150. Kerr C.A., Dunne R., Hines B.M., Zucker M., Cosgrove L., Ruszkiewicz A., Lockett T., Head R. Measuring the combinatorial expression of solute transporters and metalloproteinases transcripts in colorectal cancer. BMC Res. Notes 2009, 2:164.
151. Kiilerich K., Ringholm S., Biensø R.S., Fisher J.P., Iversen N., van Hall G., Wojtaszewski J.F., Saltin B., Lundby C., Calbet J.A., Pilegaard H. Exercise-induced pyruvate dehydrogenase activation is not affected by 7days of bed rest. J. Appl. Physiol. 2011, 111(3):751-757.
152. Kim H.J., Son Y.K., An W.S. Effect of sodium bicarbonate administration on mortality in patients with lactic acidosis: a retrospective analysis. PLoS One 2013, 8(6):e65283.
153. King P., Parkin H., Macdonald I.A., Barber C., Tattersall R.B. The effect of intravenous lactate on cerebral function during hypoglycaemia. Diabet. Med. 1997, 14(1):19-28.
154. King P., Kong M.F., Parkin H., MacDonald I.A., Barber C., Tattersall R.B. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin. Sci. (Lond.) 1998, 94(2):157-163.
155. Kishimoto M., Hashiramoto M., Araki S., Ishida Y., Kazumi T., Kanda E., Kasuga M. Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetologia 1995, 38(2):193-200.
156. Klein M., Weksler N., Gurman G.M. Fatal metabolic acidosis caused by thiamine deficiency. J. Emerg. Med. 2004, 26(3):301-303.
157. Klier M., Schuler C., Halestrap A.P., Sly W.S., Deitmer J.W., Becker H.M. Transport activity of the high-affinity monocarboxylate transporter MCT2 is enhanced by extracellular carbonic anhydrase IV but not by intracellular carbonic anhydrase II. J. Biol. Chem. 2011, 286(31):27781-27791.
158. Koeck T., Olsson A.H., Nitert M.D., Sharoyko V.V., Ladenvall C., Kotova O., Reiling E., Rönn T., Parikh H., Taneera J., Eriksson J.G., Metodiev M.D., Larsson N.G., Balhuizen A., Luthman H., Stančáková A., Kuusisto J., Laakso M., Poulsen P., Vaag A., Groop L., Lyssenko V., Mulder H., Ling C. A common variant in TFB1M is associated with reduced insulin secretion and increased future risk of type 2 diabetes. Cell Metab. 2011, 13(1):80-91.
159. Kreisberg R.A. Lactate homeostasis and lactic acidosis. Ann. Intern. Med. 1980, 92(2 Pt 1):227-237.
160. Kreisberg R.A., Owen W.C., Siegal A.M. Hyperlacticacidemia in man: ethanol-phenformin synergism. J. Clin. Endocrinol. Metab. 1972, 34(1):29-35.
161. Kumagai S., Tanaka K., Matsuura Y., Matsuzaka A., Hirakoba K., Asano K. Relationships of the anaerobic threshold with the 5km, 10km, and 10 mile races. Eur. J. Appl. Physiol. Occup. Physiol. 1982, 49(1):13-23.
162. Kumar A., Nugent K., Kalakunja A., Pirtle F. Severe acidosis in a patient with type 2 diabetes mellitus, hypertension, and renal failure. Chest 2003, 123(5):1726-1729.
163. Landau B.R., Wahren J., Ekberg K., Previs S.F., Yang D., Brunengraber H. Limitations in estimating gluconeogenesis and Cori cycling from mass isotopomer distributions using [U-13C6]glucose. Am. J. Physiol. 1998, 274(5 Pt 1):E954-E961.
164. Lanza I.R., Nair K.S. Muscle mitochondrial changes with aging and exercise. Am. J. Clin. Nutr. 2009, 89(1):467S-471S.
165. Lanza I.R., Zhang S., Ward L.E., Karakelides H., Raftery D., Nair K.S. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One 2010, 5(5):e10538.
166. Larsen T.S., Rasmussen P., Overgaard M., Secher N.H., Nielsen H.B. Non-selective beta-adrenergic blockade prevents reduction of the cerebral metabolic ratio during exhaustive exercise in humans. J. Physiol. 2008, 586(Pt 11):2807-2815.
167. Lauritzen F., de Lanerolle N.C., Lee T.S., Spencer D.D., Kim J.H., Bergersen L.H., Eid T. Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus. Neurobiol. Dis. 2011, 41(2):577-584.
168. Lazzeri C., Valente S., Chiostri M., Picariello C., Gensini G.F. Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diab. Vasc. Dis. Res. 2011, 8(1):35-42.
169. + symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(40):16663-16668.
170. Le A., Cooper C.R., Gouw A.M., Dinavahi R., Maitra A., Deck L.M., Royer R.E., Vander Jagt D.L., Semenza G.L., Dang C.V. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(5):2037-2042.
171. Leatherdale B.A., Chase R.A., Rogers J., Alberti K.G., Davies P., Record C.O. Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin. Sci. (Lond.) 1980, 59(3):191-198.
172. Lefort N., Glancy B., Bowen B., Willis W.T., Bailowitz Z., De Filippis E.A., Brophy C., Meyer C., Højlund K., Yi Z., Mandarino L.J. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010, 59(10):2444-2452.
173. Lemire J., Mailloux R.J., Appanna V.D. Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS One 2008, 3(2):e1550.
174. Levraut J., Ciebiera J.P., Chave S., Rabary O., Jambou P., Carles M., Grimaud D. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am. J. Respir. Crit. Care Med. 1998, 157(4 Pt 1):1021-1026.
175. Levy B. Lactate and shock state: the metabolic view. Curr. Opin. Crit. Care 2006, 12(4):315-321.
176. Li H., Myeroff L., Smiraglia D., Romero M.F., Pretlow T.P., Kasturi L., Lutterbaugh J., Rerko R.M., Casey G., Issa J.P., Willis J., Willson J.K., Plass C., Markowitz S.D. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(14):8412-8417.
177. Lin R.Y., Vera J.C., Chaganti R.S., Golde D.W. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J. Biol. Chem. 1998, 273(44):28959-28965.
178. Lovejoy J., Mellen B., Digirolamo M. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int. J. Obes. 1990, 14(10):843-855.
179. Lovejoy J., Newby F.D., Gebhart S.S., DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 1992, 41(1):22-27.
180. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307(5708):384-387.
181. Lu J., Zello G.A., Randell E., Adeli K., Krahn J., Meng Q.H. Closing the anion gap: contribution of d-lactate to diabetic ketoacidosis. Clin. Chim. Acta 2011, 412(3-4):286-291.
182. Lubow J.M., Pinon I.G., Avogaro A., Cobelli C., Treeson D.M., Mandeville K.A., Toffolo G., Boyle P.J. Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit. Am. J. Physiol. Endocrinol. Metab. 2006, 290(1):E149-E153.
183. MacRae H.H., Noakes T.D., Dennis S.C. Effects of endurance training on lactate removal by oxidation and gluconeogenesis during exercise. Pflugers Arch. 1995, 430(6):964-970.
184. Majander A., Suomalainen A., Vettenranta K., Sariola H., Perkkio M., Holmberg C., Pihko H. Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr. Res. 1991, 30(4):327-330.
185. Majer M., Popov K.M., Harris R.A., Bogardus C., Prochazka M. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol. Genet. Metab. 1998, 65(2):181-186.
186. Martin Negrier M.L., Coquet M., Moretto B.T., Lacut J.Y., Dupon M., Bloch B., Lestienne P., Vital C. Partial triplication of mtDNA in maternally transmitted diabetes mellitus and deafness. Am. J. Hum. Genet. 1998, 63(4):1227-1232.
187. +-coupled transporter for active uptake of l-lactate and ketone bodies in the brain. J. Neurochem. 2006, 98(1):279-288.
188. Matthews L.T., Giddy J., Ghebremichael M., Hampton J., Guarino A.J., Ewusi A., Carver E., Axten K., Geary M.C., Gandhi R.T., Bangsberg D.R. A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. PLoS One 2011, 6(4):e18736.
189. McKelvie R.S., Lindinger M.I., Heigenhauser G.J., Sutton J.R., Jones N.L. Renal responses to exercise-induced lactic acidosis. Am. J. Physiol. 1989, 257(1 Pt 2):R102-R108.
190. Meert K.L., McCaulley L., Sarnaik A.P. Mechanism of lactic acidosis in children with acute severe asthma. Pediatr. Crit. Care Med. 2012, 13(1):28-31.
191. Menshikova E.V., Ritov V.B., Toledo F.G., Ferrell R.E., Goodpaster B.H., Kelley D.E. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am. J. Physiol. Endocrinol. Metab. 2005, 288(4):E818-E825.
192. Messonnier L.A., Emhoff C.A., Fattor J.A., Horning M.A., Carlson T.J., Brooks G.A. Lactate kinetics at the lactate threshold in trained and untrained men. J. Appl. Physiol. 2013, 114(11):1593-1602.
193. Metz L., Sirvent P., Py G., Brun J.F., Fédou C., Raynaud E., Mercier J. Relationship between blood lactate concentration and substrate utilization during exercise in type 2 diabetic postmenopausal women. Metabolism 2005, 54(8):1102-1107.
194. Meyer C., Stumvoll M., Nadkarni V., Dostou J., Mitrakou A., Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J. Clin. Invest. 1998, 102(3):619-624.
195. Meyer C., Stumvoll M., Dostou J., Welle S., Haymond M., Gerich J. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282(2):E428-E434.
196. Meyer C., Stumvoll M., Welle S., Woerle H.J., Haymond M., Gerich J. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285(4):E819-E826.
197. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., Goyal M., Fuchs B.D., Shah C.V., Bellamy S.L., Christie J.D. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med. 2009, 37(5):1670-1677.
198. Misu H., Takamura T., Matsuzawa N., Shimizu A., Ota T., Sakurai M., Ando H., Arai K., Yamashita T., Honda M., Kaneko S. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 2007, 50(2):268-277.
199. Mitchell A.M., Cournand A. The fate of circulating lactic acid in the human lung. J. Clin. Invest. 1955, 34(3):471-476.
200. Mitrakou A., Kelley D., Veneman T., Jenssen T., Pangburn T., Reilly J., Gerich J. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 1990, 39(11):1381-1390.
201. +-coupled transporter for short-chain fatty acids. J. Biol. Chem. 2004, 279(14):13293-13296.
202. Mogensen M., Sahlin K., Fernström M., Glintborg D., Vind B.F., Beck-Nielsen H., Højlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007, 56(6):1592-1599.
203. Moon S., Kim J.H., Han J.H., Ko S.H., Ahn Y.B., Yang S.H., Song K.H. Novel compound heterozygous mutations in the fructose-1,6-bisphosphatase gene cause hypoglycemia and lactic acidosis. Metabolism 2011, 60(1):107-113.
204. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34(3):267-273.
205. Müller M., Holmäng A., Andersson O.K., Eichler H.G., Lönnroth P. Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance test. Am. J. Physiol. 1996, 271(6 Pt 1):E1003-E1007.
206. Munoz J., Stoltenberg M. Severe lactic acidosis in a patient with metastatic prostate cancer. J. Cancer Res. Ther. 2011, 7(2):201-202.
207. Murray C.M., Hutchinson R., Bantick J.R., Belfield G.P., Benjamin A.D., Brazma D., Bundick R.V., Cook I.D., Craggs R.I., Edwards S., Evans L.R., Harrison R., Holness E., Jackson A.P., Jackson C.G., Kingston L.P., Perry M.W., Ross A.R., Rugman P.A., Sidhu S.S., Sullivan M., Taylor-Fishwick D.A., Walker P.C., Whitehead Y.M., Wilkinson D.J., Wright A., Donald D.K. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat. Chem. Biol. 2005, 1(7):371-376.
208. Nair K.S., Bigelow M.L., Asmann Y.W., Chow L.S., Coenen-Schimke J.M., Klaus K.A., Guo Z.K., Sreekumar R., Irving B.A. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008, 57(5):1166-1175.
209. Naito E., Ito M., Takeda E., Yokota I., Yoshijima S., Kuroda Y. Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia. Pediatr. Res. 1994, 36(3):340-346.
210. Natali A., Buzzigoli G., Taddei S., Santoro D., Cerri M., Pedrinelli R., Ferrannini E. Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes 1990, 39(4):490-500.
211. Nichol A.D., Egi M., Pettila V., Bellomo R., French C., Hart G., Davies A., Stachowski E., Reade M.C., Bailey M., Cooper D.J. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit. Care 2010, 14(1):R25.
212. Nielsen H.B., Clemmesen J.O., Skak C., Ott P., Secher N.H. Attenuated hepatosplanchnic uptake of lactate during intense exercise in humans. J. Appl. Physiol. 2002, 92(4):1677-1683.
213. Ohlson L.O., Larsson B., Bjorntorp P., Eriksson H., Svardsudd K., Welin L., Tibblin G., Wilhelmsen L. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988, 31(11):798-805.
214. Olsson A.H., Yang B.T., Hall E., Taneera J., Salehi A., Nitert M.D., Ling C. Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes. Eur. J. Endocrinol. 2011, 165(4):589-595.
215. Ortenblad N., Mogensen M., Petersen I., Højlund K., Levin K., Sahlin K., Beck-Nielsen H., Gaster M. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta 2005, 1741(1-2):206-214.
216. Otonkoski T., Jiao H., Kaminen-Ahola N., Tapia-Paez I., Ullah M.S., Parton L.E., Schuit F., Quintens R., Sipila I., Mayatepek E., Meissner T., Halestrap A.P., Rutter G.A., Kere J. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am. J. Hum. Genet. 2007, 81(3):467-474.
217. Overgaard M., Rasmussen P., Bohm A.M., Seifert T., Brassard P., Zaar M., Homann P., Evans K.A., Nielsen H.B., Secher N.H. Hypoxia and exercise provoke both lactate release and lactate oxidation by the human brain. FASEB J. 2012, 26(7):3012-3020.
218. Owen O.E., Felig P., Morgan A.P., Wahren J., Cahill G.F. Liver and kidney metabolism during prolonged starvation. J. Clin. Invest. 1969, 48(3):574-583.
219. Owen O.E., Reichle F.A., Mozzoli M.A., Kreulen T., Patel M.S., Elfenbein I.B., Golsorkhi M., Chang K.H., Rao N.S., Sue H.S., Boden G. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J. Clin. Invest. 1981, 68(1):240-252.
220. Pagliara A.S., Karl I.E., Keating J.P., Brown B.I., Kipnis D.M. Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. J. Clin. Invest. 1972, 51(8):2115-2123.
221. Paksu M.S., Kalkan G., Asilioglu N., Paksu S., Dinler G. Gluconeogenesis defect presenting with resistant hyperglycemia and acidosis. Pediatr. Emerg. Care 2011, 27(12):1180-1181.
222. Patel K.P., O'Brien T.W., Subramony S.H., Shuster J., Stacpoole P.W. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol. Genet. Metab. 2012, 106(3):385-394.
223. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(14):8466-8471.
224. Perriello G., Jorde R., Nurjhan N., Stumvoll M., Dailey G., Jenssen T., Bier D.M., Gerich J.E. Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am. J. Physiol. 1995, 269(3 Pt 1):E443-E450.
225. Philp N.J., Wang D., Yoon H., Hjelmeland L.M. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 2003, 44(4):1716-1721.
226. + transport capacity in human skeletal muscle. Am. J. Physiol. 1999, 276(2 Pt 1):E255-E261.
227. + transporter isoforms MCT1 and MCT4 in human skeletal muscle. Am. J. Physiol. 1999, 276(5 Pt 1):E843-E848.
228. Price N.T., Jackson V.N., Halestrap A.P. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem. J. 1998, 329(Pt 2):321-328.
229. Prichard J., Rothman D., Novotny E., Petroff O., Kuwabara T., Avison M., Howseman A., Hanstock C., Shulman R. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(13):5829-5831.
230. Queiros O., Preto A., Pacheco A., Pinheiro C., Azevedo-Silva J., Moreira R., Pedro M., Ko Y.H., Pedersen P.L., Baltazar F., Casal M. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate. J. Bioenerg. Biomembr. 2012, 44(1):141-153.
231. Quinonez S.C., Leber S.M., Martin D.M., Thoene J.G., Bedoyan J.K. Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency. Pediatr. Neurol. 2013, 48(1):67-72.
232. Qvisth V., Hagström-Toft E., Moberg E., Sjöberg S., Bolinder J. Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am. J. Physiol. Endocrinol. Metab. 2007, 292(3):E709-E714.
233. Radziuk J., Inculet R. The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man. Diabetes 1983, 32(11):977-981.
234. Reardon W., Ross R.J., Sweeney M.G., Luxon L.M., Pembrey M.E., Harding A.E., Trembath R.C. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992, 340(8832):1376-1379.
235. Reaven G.M., Hollenbeck C., Jeng C.Y., Wu M.S., Chen Y.D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes 1988, 37(8):1020-1024.
236. Record C.O., Iles R.A., Cohen R.D., Williams R. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975, 16(2):144-149.
237. Record C.O., Chase R.A., Williams R., Appleton D. Disturbances of lactate metabolism in patients with liver damage due to paracetamol overdose. Metabolism 1981, 30(7):638-643.
238. Remes A.M., Majamaa K., Herva R., Hassinen I.E. Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation. Neurology 1993, 43(5):1015-1020.
239. 13C-NMR study. Toxicol. Appl. Pharmacol. 2010, 242(1):9-17.
240. 2. J. Appl. Physiol. 1998, 85(2):627-634.
241. Rindi G., Casirola D., Poggi V., De Vizia B., Patrini C., Laforenza U. Thiamine transport by erythrocytes and ghosts in thiamine-responsive megaloblastic anaemia. J. Inherit. Metab. Dis. 1992, 15(2):231-242.
242. Ritzhaupt A., Wood I.S., Ellis A., Hosie K.B., Shirazi-Beechey S.P. Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport l-lactate as well as butyrate. J. Physiol. 1998, 513(Pt 3):719-732.
243. Rochester D.F., Wichern W.A., Fritts H.W., Caldwell P.R., Lewis M.L., Giuntini C., Garfield J.W. Arteriovenous differences of lactate and pyruvate across healthy and diseased human lung. Am. Rev. Respir. Dis. 1973, 107(3):442-448.
244. Roth B., Woo O., Blanc P. Early metabolic acidosis and coma after acetaminophen ingestion. Ann. Emerg. Med. 1999, 33(4):452-456.
245. Rotig A., Bessis J.L., Romero N., Cormier V., Saudubray J.M., Narcy P., Lenoir G., Rustin P., Munnich A. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am. J. Hum. Genet. 1992, 50(2):364-370.
246. Sahlin K., Katz A., Henriksson J. Redox state and lactate accumulation in human skeletal muscle during dynamic exercise. Biochem. J. 1987, 245(2):551-556.
247. Saksena S., Theegala S., Bansal N., Gill R.K., Tyagi S., Alrefai W.A., Ramaswamy K., Dudeja P.K. Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297(5):G878-G885.
248. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2010, 4:CD002967.
249. Sandberg Y., Rood P.P., Russcher H., Zwaans J.J., Weige J.D., van Daele P.L. Falsely elevated lactate in severe ethylene glycol intoxication. Neth. J. Med. 2010, 68(1):320-323.
250. Scale T., Harvey J.N. Diabetes, metformin and lactic acidosis. Clin. Endocrinol. (Oxf) 2011, 74(2):191-196.
251. Segre A.V., Groop L., Mootha V.K., Daly M.J., Altshuler D. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 2010, 6(8).
252. Shah A.D., Wood D.M., Dargan P.I. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br. J. Clin. Pharmacol. 2011, 71(1):20-28.
253. Shangraw R.E., Rabkin J.M., Lopaschuk G.D. Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis. Am. J. Physiol. 1998, 274(3 Pt 1):G569-G577.
254. Simoneau J.A., Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 1997, 83(1):166-171.
255. Singleton C.K., Martin P.R. Molecular mechanisms of thiamine utilization. Curr. Mol. Med. 2001, 1(2):197-207.
256. Sjöstrand M., Holmäng A., Strindberg L., Lönnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am. J. Physiol. Endocrinol. Metab. 2000, 279(5):E1097-E1103.
257. Snogdal L.S., Wod M., Grarup N., Vestmar M., Sparso T., Jorgensen T., Lauritzen T., Beck-Nielsen H., Henriksen J.E., Pedersen O., Hansen T., Hojlund K. Common variation in oxidative phosphorylation genes is not a major cause of insulin resistance or type 2 diabetes. Diabetologia 2012, 55(2):340-348.
258. Soronen J., Laurila P.P., Naukkarinen J., Surakka I., Ripatti S., Jauhiainen M., Olkkonen V.M., Yki-Järvinen H. Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med. Genomics 2012, 5:9.
259. Spriet L.L., Tunstall R.J., Watt M.J., Mehan K.A., Hargreaves M., Cameron-Smith D. Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting. J. Appl. Physiol. 2004, 96(6):2082-2087.
260. Sproule D.M., Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann. N. Y. Acad. Sci. 2008, 1142:133-158.
261. Stacpoole P.W., Kerr D.S., Barnes C., Bunch S.T., Carney P.R., Fennell E.M., Felitsyn N.M., Gilmore R.L., Greer M., Henderson G.N., Hutson A.D., Neiberger R.E., O'Brien R.G., Perkins L.A., Quisling R.G., Shroads A.L., Shuster J.J., Silverstein J.H., Theriaque D.W., Valenstein E. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006, 117(5):1519-1531.
262. Stades A.M., Heikens J.T., Erkelens D.W., Holleman F., Hoekstra J.B. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J. Intern. Med. 2004, 255(2):179-187.
263. Stallknecht B., Vissing J., Galbo H. Lactate production and clearance in exercise. Effects of training. A mini-review. Scand. J. Med. Sci. Sports 1998, 8(3):127-131.
264. Stanley W.C., Gertz E.W., Wisneski J.A., Neese R.A., Morris D.L., Brooks G.A. Lactate extraction during net lactate release in legs of humans during exercise. J. Appl. Physiol. 1986, 60(4):1116-1120.
265. Steller J., Gargus J.J., Gibbs L.H., Hasso A.N., Kimonis V.E. Mild phenotype in a male with pyruvate dehydrogenase complex deficiency associated with novel hemizygous in-frame duplication of the E1alpha subunit gene (PDHA1). Neuropediatrics 2014, 45(1):56-60.
266. Stringer W., Wasserman K., Casaburi R., Porszasz J., Maehara K., French W. Lactic acidosis as a facilitator of oxyhemoglobin dissociation during exercise. J. Appl. Physiol. 1994, 76(4):1462-1467.
267. Stumvoll M., Chintalapudi U., Perriello G., Welle S., Gutierrez O., Gerich J. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J. Clin. Invest. 1995, 96(5):2528-2533.
268. Stumvoll M., Meyer C., Perriello G., Kreider M., Welle S., Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am. J. Physiol. 1998, 274(5 Pt 1):E817-E826.
269. Stunff C.L., Bougneres P.F. Alterations of plasma lactate and glucose metabolism in obese children. Am. J. Physiol. 1996, 271(5 Pt 1):E814-E820.
270. Suter P.M., Haller J., Hany A., Vetter W. Diuretic use: a risk for subclinical thiamine deficiency in elderly patients. J. Nutr. Health Aging 2000, 4(2):69-71.
271. Szendroedi J., Schmid A.I., Meyerspeer M., Cervin C., Kacerovsky M., Smekal G., Gräser-Lang S., Groop L., Roden M. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 2009, 32(4):677-679.
272. Talasniemi J.P., Pennanen S., Savolainen H., Niskanen L., Liesivuori J. Analytical investigation: assay of d-lactate in diabetic plasma and urine. Clin. Biochem. 2008, 41(13):1099-1103.
273. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6(5):389-402.
274. Thorburn A.W., Gumbiner B., Bulacan F., Wallace P., Henry R.R. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J. Clin. Invest. 1990, 85(2):522-529.
275. Toledo F.G., Menshikova E.V., Azuma K., Radiková Z., Kelley C.A., Ritov V.B., Kelley D.E. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 2008, 57(4):987-994. 10.2337/db07-1429.
276. Tonsgard J.H., Huttenlocher P.R., Thisted R.A. Lactic acidemia in Reye's syndrome. Pediatrics 1982, 69(1):64-69.
277. Ullah M.S., Davies A.J., Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 2006, 281(14):9030-9037.
278. van den Berghe G. Disorders of gluconeogenesis. J. Inherit. Metab. Dis. 1996, 19(4):470-477.
279. van den Ouweland J.M., Lemkes H.H., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A., van de Kamp J.J., Maassen J.A. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1992, 1(5):368-371.
280. van den Ouweland J.M., Lemkes H.H., Trembath R.C., Ross R., Velho G., Cohen D., Froguel P., Maassen J.A. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetes 1994, 43(6):746-751.
281. van der Merwe M.T., Schlaphoff G.P., Crowther N.J., Boyd I.H., Gray I.P., Joffe B.I., Lonnroth P.N. Lactate and glycerol release from adipose tissue in lean, obese, and diabetic women from South Africa. J. Clin. Endocrinol. Metab. 2001, 86(7):3296-3303.
282. van Hall G., Strømstad M., Rasmussen P., Jans O., Zaar M., Gam C., Quistorff B., Secher N.H., Nielsen H.B. Blood lactate is an important energy source for the human brain. J. Cereb. Blood Flow Metab. 2009, 29(6):1121-1129.
283. Van Hove J.L., Saenz M.S., Thomas J.A., Gallagher R.C., Lovell M.A., Fenton L.Z., Shanske S., Myers S.M., Wanders R.J., Ruiter J., Turkenburg M., Waterham H.R. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr. Res. 2010, 68(2):159-164.
284. Vermeulen R.P., Hoekstra M., Nijsten M.W., van der Horst I.C., van Pelt L.J., Jessurun G.A., Jaarsma T., Zijlstra F., van den Heuvel A.F. Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study. Crit. Care 2010, 14(5):R164.
285. Wahren J., Felig P., Ahlborg G., Jorfeldt L. Glucose metabolism during leg exercise in man. J Clin Invest. 1971, 50(12):2715-2725.
286. Walker M., Taylor R.W., Turnbull D.M. Mitochondrial diabetes. Diabet. Med. 2005, 22(Suppl. 4):18-20.
287. Walsh T.S., McLellan S., Mackenzie S.J., Lee A. Hyperlactatemia and pulmonary lactate production in patients with fulminant hepatic failure. Chest 1999, 116(2):471-476.
288. Wang M., Wang X.C., Zhang Z.Y., Mou B., Hu R.M. Impaired mitochondrial oxidative phosphorylation in multiple insulin-sensitive tissues of humans with type 2 diabetes mellitus. J. Int. Med. Res. 2010, 38(3):769-781.
289. Waterhouse C., Keilson J. Cori cycle activity in man. J. Clin. Invest. 1969, 48(12):2359-2366.
290. Watkins P.J., Smith J.S., Fitzgerald M.G., Malins J.M. Lactic acidosis in diabetes. Br. Med. J. 1969, 1(5646):744-747.
291. Watts J.A., Kline J.A. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad. Emerg. Med. 2003, 10(9):985-997.
292. Willis M.S., Cairns B.A., Purdy A., Bortsov A.V., Jones S.W., Ortiz-Pujols S.M., Willis T.M., Joyner B.L. Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature. Int. J. Burns Trauma 2013, 3(1):1-8.
293. Wisneski J.A., Gertz E.W., Neese R.A., Gruenke L.D., Morris D.L., Craig J.C. Metabolic fate of extracted glucose in normal human myocardium. J. Clin. Invest. 1985, 76(5):1819-1827.
294. Woerle H.J., Meyer C., Dostou J.M., Gosmanov N.R., Islam N., Popa E., Wittlin S.D., Welle S.L., Gerich J.E. Pathways for glucose disposal after meal ingestion in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 284(4):E716-E725.
295. Woerle H.J., Szoke E., Meyer C., Dostou J.M., Wittlin S.D., Gosmanov N.R., Welle S.L., Gerich J.E. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2006, 290(1):E67-E77.
296. Woll P.J., Record C.O. Lactate elimination in man: effects of lactate concentration and hepatic dysfunction. Eur. J. Clin. Invest. 1979, 9(5):397-404.
297. Yánez A.J., Nualart F., Droppelmann C., Bertinat R., Brito M., Concha I.I., Slebe J.C. Broad expression of fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney. J. Cell. Physiol. 2003, 197(2):189-197.
298. Yasuda T., Ozawa S., Shiba C., Maeba T., Kanazawa T., Sugiyama M., Owada S., Ishida M. d-lactate metabolism in patients with chronic renal failure undergoing CAPD. Nephron 1993, 63(4):416-422.
299. Yki-Jarvinen H., Nikkila E.A. Ethanol decreases glucose utilization in healthy man. J. Clin. Endocrinol. Metab. 1985, 61(5):941-945.
300. Yki-Jarvinen H., Bogardus C., Foley J.E. Regulation of plasma lactate concentration in resting human subjects. Metabolism 1990, 39(8):859-864.
301. Zar T., Yusufzai I., Sullivan A., Graeber C. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. Nat. Clin. Pract. Nephrol. 2007, 3(9):515-520.
302. Zawadzki J.K., Wolfe R.R., Mott D.M., Lillioja S., Howard B.V., Bogardus C. Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes 1988, 37(2):154-159.
303. Zhang D.L., Jiang Z.W., Jiang J., Cao B., Li J.S. d-lactic acidosis secondary to short bowel syndrome. Postgrad. Med. J. 2003, 79(928):110-112.
304. Zhang Y., Bao Y.L., Wu Y., Yu C.L., Sun Y., Li Y.X. Identification and characterization of the human SLC5A8 gene promoter. Cancer Genet. Cytogenet. 2010, 196(2):124-132.
305. Zosel A., Egelhoff E., Heard K. Severe lactic acidosis after an iatrogenic propylene glycol overdose. Pharmacotherapy 2010, 30(2):219.
306. Zu X.L., Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem. Biophys. Res. Commun. 2004, 313(3):459-465.